{"id":7760,"date":"2025-02-18T11:30:41","date_gmt":"2025-02-18T08:30:41","guid":{"rendered":"https:\/\/www.chemi-pharm.com\/?p=7760"},"modified":"2025-02-19T15:46:14","modified_gmt":"2025-02-19T12:46:14","slug":"digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon","status":"publish","type":"post","link":"https:\/\/chemi-pharm.com\/et\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\/","title":{"rendered":"Digip\u00f6\u00f6rde toetusprogrammiga viiakse ellu 2025. aasta digivisioon"},"content":{"rendered":"\n

AS Chemi-Pharm viib Ettev\u00f5tete digip\u00f6\u00f6rde toetusprogrammi raames ajavahemikul 01.10.2024 – 31.12.2025 ellu oma 2025 aasta digivisiooni.<\/p>\n\n\n\n

Projekti eesm\u00e4rk on uute v\u00f5i olemasolevate digitaalsete tehnoloogiate ja lahenduste kasutuselev\u00f5tmise v\u00f5i parendamise kaudu t\u00f5hustada kvaliteedijuhtimisega seotud protsesse, parandada kliendituge ning suurendada \u00e4ritegevuse j\u00e4lgitavust. Sellest tulenevalt on digip\u00f6\u00f6rde fookuses kvaliteedijuhtimiss\u00fcsteemi digitaliseerimine, kliendikogemuse parandamine, anal\u00fc\u00fcsiv\u00f5imekuse kasvatamine ning IT-infrastruktuuri haldamise t\u00f5hustamine.<\/p>\n\n\n\n

Projekti kogumaksumus on 230 000 eurot, millest Euroopa Liidu taasterahastu NextGenerationEU vahenditest kaetakse kuni 115 000 eurot.<\/p>\n\n\n\n

\"\"<\/figure>\n","protected":false},"excerpt":{"rendered":"AS Chemi-Pharm viib Ettev\u00f5tete digip\u00f6\u00f6rde toetusprogrammi raames ajavahemikul 01.10.2024 – 31.12.2025 ellu oma 2025 aasta digivisiooni. Projekti eesm\u00e4rk on uute v\u00f5i olemasolevate digitaalsete tehnoloogiate ja lahenduste kasutuselev\u00f5tmise v\u00f5i parendamise kaudu t\u00f5hustada kvaliteedijuhtimisega seotud protsesse, parandada kliendituge ning suurendada \u00e4ritegevuse j\u00e4lgitavust. Sellest tulenevalt on digip\u00f6\u00f6rde fookuses kvaliteedijuhtimiss\u00fcsteemi digitaliseerimine, kliendikogemuse parandamine, anal\u00fc\u00fcsiv\u00f5imekuse kasvatamine ning IT-infrastruktuuri haldamise t\u00f5hustamine. […]","protected":false},"author":13,"featured_media":7712,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","ngg_post_thumbnail":0,"footnotes":""},"categories":[10],"tags":[],"class_list":["post-7760","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uudised-est"],"acf":[],"yoast_head":"\nDigip\u00f6\u00f6rde toetusprogrammiga viiakse ellu 2025. aasta digivisioon - Chemi-Pharm<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/chemi-pharm.com\/et\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\/\" \/>\n<meta property=\"og:locale\" content=\"et_EE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Digip\u00f6\u00f6rde toetusprogrammiga viiakse ellu 2025. aasta digivisioon - Chemi-Pharm\" \/>\n<meta property=\"og:description\" content=\"AS Chemi-Pharm viib Ettev\u00f5tete digip\u00f6\u00f6rde toetusprogrammi raames ajavahemikul 01.10.2024 – 31.12.2025 ellu oma 2025 aasta digivisiooni. Projekti eesm\u00e4rk on uute v\u00f5i olemasolevate digitaalsete tehnoloogiate ja lahenduste kasutuselev\u00f5tmise v\u00f5i parendamise kaudu t\u00f5hustada kvaliteedijuhtimisega seotud protsesse, parandada kliendituge ning suurendada \u00e4ritegevuse j\u00e4lgitavust. Sellest tulenevalt on digip\u00f6\u00f6rde fookuses kvaliteedijuhtimiss\u00fcsteemi digitaliseerimine, kliendikogemuse parandamine, anal\u00fc\u00fcsiv\u00f5imekuse kasvatamine ning IT-infrastruktuuri haldamise t\u00f5hustamine. […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/chemi-pharm.com\/et\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemi-Pharm\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/chemipharmeesti\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-18T08:30:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-19T12:46:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"674\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Justin Hein\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\\\/\"},\"author\":{\"name\":\"Justin Hein\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#\\\/schema\\\/person\\\/edf286ff172528816261c5720fe3fc91\"},\"headline\":\"Digip\u00f6\u00f6rde toetusprogrammiga viiakse ellu 2025. aasta digivisioon\",\"datePublished\":\"2025-02-18T08:30:41+00:00\",\"dateModified\":\"2025-02-19T12:46:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\\\/\"},\"wordCount\":85,\"publisher\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/chemi-pharm.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg\",\"articleSection\":[\"Uudised eestikeelsed\"],\"inLanguage\":\"et\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\\\/\",\"url\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\\\/\",\"name\":\"Digip\u00f6\u00f6rde toetusprogrammiga viiakse ellu 2025. aasta digivisioon - Chemi-Pharm\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/chemi-pharm.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg\",\"datePublished\":\"2025-02-18T08:30:41+00:00\",\"dateModified\":\"2025-02-19T12:46:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\\\/#breadcrumb\"},\"inLanguage\":\"et\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\\\/#primaryimage\",\"url\":\"https:\\\/\\\/chemi-pharm.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg\",\"contentUrl\":\"https:\\\/\\\/chemi-pharm.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg\",\"width\":1200,\"height\":674},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Digip\u00f6\u00f6rde toetusprogrammiga viiakse ellu 2025. aasta digivisioon\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#website\",\"url\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/\",\"name\":\"Chemi-Pharm\",\"description\":\"Chemi-Pharm'i professionaalsed ja k\u00f5rge kvaliteediga desinfektsiooni- ja puhastusvahendid otse tootjalt\",\"publisher\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"et\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#organization\",\"name\":\"Chemi-Pharm\",\"url\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Group-17-1.svg\",\"contentUrl\":\"https:\\\/\\\/www.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Group-17-1.svg\",\"width\":282,\"height\":27,\"caption\":\"Chemi-Pharm\"},\"image\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/chemipharmeesti\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#\\\/schema\\\/person\\\/edf286ff172528816261c5720fe3fc91\",\"name\":\"Justin Hein\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g\",\"caption\":\"Justin Hein\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Digip\u00f6\u00f6rde toetusprogrammiga viiakse ellu 2025. aasta digivisioon - Chemi-Pharm","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/chemi-pharm.com\/et\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\/","og_locale":"et_EE","og_type":"article","og_title":"Digip\u00f6\u00f6rde toetusprogrammiga viiakse ellu 2025. aasta digivisioon - Chemi-Pharm","og_description":"AS Chemi-Pharm viib Ettev\u00f5tete digip\u00f6\u00f6rde toetusprogrammi raames ajavahemikul 01.10.2024 – 31.12.2025 ellu oma 2025 aasta digivisiooni. Projekti eesm\u00e4rk on uute v\u00f5i olemasolevate digitaalsete tehnoloogiate ja lahenduste kasutuselev\u00f5tmise v\u00f5i parendamise kaudu t\u00f5hustada kvaliteedijuhtimisega seotud protsesse, parandada kliendituge ning suurendada \u00e4ritegevuse j\u00e4lgitavust. Sellest tulenevalt on digip\u00f6\u00f6rde fookuses kvaliteedijuhtimiss\u00fcsteemi digitaliseerimine, kliendikogemuse parandamine, anal\u00fc\u00fcsiv\u00f5imekuse kasvatamine ning IT-infrastruktuuri haldamise t\u00f5hustamine. […]","og_url":"https:\/\/chemi-pharm.com\/et\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\/","og_site_name":"Chemi-Pharm","article_publisher":"https:\/\/www.facebook.com\/chemipharmeesti","article_published_time":"2025-02-18T08:30:41+00:00","article_modified_time":"2025-02-19T12:46:14+00:00","og_image":[{"width":1200,"height":674,"url":"https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg","type":"image\/jpeg"}],"author":"Justin Hein","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/chemi-pharm.com\/et\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\/#article","isPartOf":{"@id":"https:\/\/chemi-pharm.com\/et\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\/"},"author":{"name":"Justin Hein","@id":"https:\/\/chemi-pharm.com\/et\/#\/schema\/person\/edf286ff172528816261c5720fe3fc91"},"headline":"Digip\u00f6\u00f6rde toetusprogrammiga viiakse ellu 2025. aasta digivisioon","datePublished":"2025-02-18T08:30:41+00:00","dateModified":"2025-02-19T12:46:14+00:00","mainEntityOfPage":{"@id":"https:\/\/chemi-pharm.com\/et\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\/"},"wordCount":85,"publisher":{"@id":"https:\/\/chemi-pharm.com\/et\/#organization"},"image":{"@id":"https:\/\/chemi-pharm.com\/et\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\/#primaryimage"},"thumbnailUrl":"https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg","articleSection":["Uudised eestikeelsed"],"inLanguage":"et"},{"@type":"WebPage","@id":"https:\/\/chemi-pharm.com\/et\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\/","url":"https:\/\/chemi-pharm.com\/et\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\/","name":"Digip\u00f6\u00f6rde toetusprogrammiga viiakse ellu 2025. aasta digivisioon - Chemi-Pharm","isPartOf":{"@id":"https:\/\/chemi-pharm.com\/et\/#website"},"primaryImageOfPage":{"@id":"https:\/\/chemi-pharm.com\/et\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\/#primaryimage"},"image":{"@id":"https:\/\/chemi-pharm.com\/et\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\/#primaryimage"},"thumbnailUrl":"https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg","datePublished":"2025-02-18T08:30:41+00:00","dateModified":"2025-02-19T12:46:14+00:00","breadcrumb":{"@id":"https:\/\/chemi-pharm.com\/et\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\/#breadcrumb"},"inLanguage":"et","potentialAction":[{"@type":"ReadAction","target":["https:\/\/chemi-pharm.com\/et\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\/"]}]},{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/chemi-pharm.com\/et\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\/#primaryimage","url":"https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg","contentUrl":"https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg","width":1200,"height":674},{"@type":"BreadcrumbList","@id":"https:\/\/chemi-pharm.com\/et\/digipoorde-toetusprogrammiga-viiakse-ellu-2025-aasta-digivisioon\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/chemi-pharm.com\/et\/"},{"@type":"ListItem","position":2,"name":"Digip\u00f6\u00f6rde toetusprogrammiga viiakse ellu 2025. aasta digivisioon"}]},{"@type":"WebSite","@id":"https:\/\/chemi-pharm.com\/et\/#website","url":"https:\/\/chemi-pharm.com\/et\/","name":"Chemi-Pharm","description":"Chemi-Pharm'i professionaalsed ja k\u00f5rge kvaliteediga desinfektsiooni- ja puhastusvahendid otse tootjalt","publisher":{"@id":"https:\/\/chemi-pharm.com\/et\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/chemi-pharm.com\/et\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"et"},{"@type":"Organization","@id":"https:\/\/chemi-pharm.com\/et\/#organization","name":"Chemi-Pharm","url":"https:\/\/chemi-pharm.com\/et\/","logo":{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/chemi-pharm.com\/et\/#\/schema\/logo\/image\/","url":"https:\/\/www.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Group-17-1.svg","contentUrl":"https:\/\/www.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Group-17-1.svg","width":282,"height":27,"caption":"Chemi-Pharm"},"image":{"@id":"https:\/\/chemi-pharm.com\/et\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/chemipharmeesti"]},{"@type":"Person","@id":"https:\/\/chemi-pharm.com\/et\/#\/schema\/person\/edf286ff172528816261c5720fe3fc91","name":"Justin Hein","image":{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/secure.gravatar.com\/avatar\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g","caption":"Justin Hein"}}]}},"author_meta":{"display_name":"Justin Hein","author_link":"https:\/\/chemi-pharm.com\/et\/author\/justin\/"},"featured_img":"https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color-300x169.jpg","uagb_featured_image_src":{"full":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg",1200,674,false],"thumbnail":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color-150x150.jpg",150,150,true],"medium":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color-300x169.jpg",300,169,true],"medium_large":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color-768x431.jpg",768,431,true],"large":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color-1024x575.jpg",1024,575,true],"1536x1536":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg",1200,674,false],"2048x2048":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg",1200,674,false],"news_thumb":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color-600x337.jpg",600,337,true],"custom_thumb":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color-200x112.jpg",200,112,true]},"uagb_author_info":{"display_name":"Justin Hein","author_link":"https:\/\/chemi-pharm.com\/et\/author\/justin\/"},"uagb_comment_info":0,"uagb_excerpt":"AS Chemi-Pharm viib Ettev\u00f5tete digip\u00f6\u00f6rde toetusprogrammi raames ajavahemikul 01.10.2024 – 31.12.2025 ellu oma 2025 aasta digivisiooni. Projekti eesm\u00e4rk on uute v\u00f5i olemasolevate digitaalsete tehnoloogiate ja lahenduste kasutuselev\u00f5tmise v\u00f5i parendamise kaudu t\u00f5hustada kvaliteedijuhtimisega seotud protsesse, parandada kliendituge ning suurendada \u00e4ritegevuse j\u00e4lgitavust. Sellest tulenevalt on digip\u00f6\u00f6rde fookuses kvaliteedijuhtimiss\u00fcsteemi digitaliseerimine, kliendikogemuse parandamine, anal\u00fc\u00fcsiv\u00f5imekuse kasvatamine ning IT-infrastruktuuri haldamise t\u00f5hustamine.…","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/chemi-pharm.com\/et\/category\/uudised-est\/\" class=\"advgb-post-tax-term\">Uudised eestikeelsed<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Uudised eestikeelsed<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 1 aasta ago","modified":"Updated 1 aasta ago"},"absolute_dates":{"created":"Posted on 18\/02\/2025","modified":"Updated on 19\/02\/2025"},"absolute_dates_time":{"created":"Posted on 18\/02\/2025 11:30","modified":"Updated on 19\/02\/2025 15:46"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts\/7760","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/comments?post=7760"}],"version-history":[{"count":1,"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts\/7760\/revisions"}],"predecessor-version":[{"id":7765,"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts\/7760\/revisions\/7765"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/media\/7712"}],"wp:attachment":[{"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/media?parent=7760"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/categories?post=7760"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/tags?post=7760"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}